title: Breakdown.
authors.affiliation: Department of Medicine, University of California, San Francisco, San Francisco, California.
authors.forename: Jane M
authors.initials: JM
authors.lastname: Zhu
authors.affiliation: Department of Medicine, University of California, San Francisco, San Francisco, California.|Medical Service, San Francisco VA Medical Center, San Francisco, California.
authors.forename: David
authors.initials: D
authors.lastname: Hamel
authors.affiliation: Department of Medicine, University of California, San Francisco, San Francisco, California.|Medical Service, San Francisco VA Medical Center, San Francisco, California.
authors.forename: Gurpreet
authors.initials: G
authors.lastname: Dhaliwal
authors.affiliation: Department of Medicine, University of California, San Francisco, San Francisco, California.
authors.forename: Marcia
authors.initials: M
authors.lastname: Glass
authors.affiliation: Department of Medicine, University of California, San Francisco, San Francisco, California.
authors.forename: Bradley
authors.initials: B
authors.lastname: Sharpe
authors.affiliation: Department of Medicine, University of California, San Francisco, San Francisco, California.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Kim
authors.affiliation: Department of Medicine, University of California, San Francisco, San Francisco, California.
authors.forename: Bradley
authors.initials: B
authors.lastname: Monash
mesh_terms: D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D016360:Clostridioides difficile / Q000302:isolation & purification; D003015:Clostridium Infections / Q000188:drug therapy; D063005:Health Information Systems; D006801:Humans; D008297:Male; D008875:Middle Aged; D010264:Paraplegia / Q000150:complications; D010878:Piperacillin / Q000009:adverse effects*; D003668:Pressure Ulcer / Q000150:complications / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D010878:Piperacillin